© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Universe Pharmaceuticals Inc. (UPC) stock surged +4.23%, trading at $2.96 on NASDAQ, up from the previous close of $2.84. The stock opened at $2.60, fluctuating between $2.60 and $2.99 in the recent session.
| Filing Date | Accepted Date | |
|---|---|---|
| Filing Date | Accepted Date | |
|---|---|---|
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Jun 26, 2026 | 2.60 | 2.99 | 2.60 | 2.96 | 14.98M |
| Jun 25, 2026 | 2.73 | 2.84 | 2.70 | 2.84 | 2.41K |
| Jun 24, 2026 | 3.00 | 3.00 | 2.73 | 2.95 | 11.03K |
| Jun 23, 2026 | 2.80 | 3.04 | 2.65 | 3.04 | 11.88K |
| Jun 22, 2026 | 2.81 | 2.92 | 2.77 | 2.85 | 17.03K |
| Jun 18, 2026 | 2.80 | 3.00 | 2.80 | 2.95 | 14.06K |
| Jun 17, 2026 | 2.82 | 3.00 | 2.78 | 2.91 | 40.96K |
| Jun 16, 2026 | 2.75 | 3.15 | 2.63 | 2.89 | 5.33M |
| Jun 15, 2026 | 3.14 | 3.26 | 3.04 | 3.12 | 5.11K |
| Jun 12, 2026 | 3.11 | 3.24 | 3.10 | 3.24 | 5.08K |
| Jun 11, 2026 | 3.54 | 3.69 | 3.25 | 3.25 | 23.01K |
| Jun 10, 2026 | 3.28 | 3.72 | 3.16 | 3.63 | 28.85K |
| Jun 09, 2026 | 3.51 | 3.70 | 3.01 | 3.37 | 672.66K |
| Jun 08, 2026 | 3.18 | 3.62 | 2.97 | 3.62 | 31.97K |
| Jun 05, 2026 | 3.05 | 3.30 | 2.90 | 3.27 | 8.37K |
| Jun 04, 2026 | 3.19 | 3.41 | 3.19 | 3.33 | 1.23K |
| Jun 03, 2026 | 3.31 | 3.44 | 3.19 | 3.44 | 4.18K |
| Jun 01, 2026 | 3.40 | 3.40 | 3.05 | 3.37 | 9.69K |
| May 29, 2026 | 2.98 | 3.57 | 2.98 | 3.50 | 28.44K |
| May 28, 2026 | 2.80 | 3.00 | 2.80 | 2.85 | 8.92K |
Universe Pharmaceuticals Inc. (UPC) operates as a pharmaceutical enterprise primarily focused on the Chinese market. The company specializes in the production, promotion, and sale of products derived from traditional Chinese medicine (TCM). These remedies are designed to address common chronic health issues prevalent among the elderly, promoting physical well-being and longevity, in addition to offering medications for cold and flu symptoms. Beyond its own manufactured goods, UPC also functions as a distributor and vendor for a diverse range of third-party products. This extensive portfolio includes biomedical drugs, medical instruments, traditional Chinese medicine 'pieces' (raw ingredients), and various dietary supplements. Its clientele spans across the healthcare sector, encompassing other pharmaceutical companies, hospitals, clinics, and major drugstore chains. Established in 2019, the company's operations are headquartered in Ji'An, China, and it functions as a subsidiary of Sununion Holding Group Limited.
| Employees | 225 |
| Beta | 1.6 |
| Sales or Revenue | $32.31M |
| 5Y Sales Change% | 5.564% |
| Fiscal Year Ends | September |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |